gave | Saturday, May 15, 2021 – 17:55 | Last Updated: 15 05 2021 – 17:55
The company’s COVID-19 test kits of the company, which started R & D as soon as the new coronavirus epidemic occurred in China, are exported to 50 countries in the world, especially European countries such as England, Italy and France. Stating that they brought about 50 million dollars in foreign currency to Turkey in 2020, Anatolia Tanı A.Ş., Chairman of the Board of Directors, Alper Akyüz said, “We have established a new and much larger R&D center with an investment of 80 million lira. we will continue, “he said.
“DEVELOPMENT OF THE CORONAVIRUS TEST KIT STARTED AT THE END OF 2019”
“NEW R&D CENTER WITH INVESTMENT OF 80 MILLION LIRA”
Stating that the need for test kits may continue for many years, Akyüz informed that they have established a new and much larger R&D center with an investment of 80 million TL. Akyüz said, “We maintain a similar pace in 2021. Although the vaccination studies continue to gain speed, the need for testing is not over. Our test kit production will continue to increase in the coming years. The need seems to continue for many years. We are here to meet this demand. We are working with our strength. Our number of employees has increased a lot over the years. We currently have more than 100 personnel, 35 of which are in our R&D center. We will move to our new R&D center in the coming months. We hope that we will be able to work with many more researchers here, “he said.
“ONE HUNDRED PERCENT PROBABILITY OF ACCURATE RESULT OF A WELL DESIGNED PCR KIT”
Alper Akyüz, who mentioned that some PCR test kits give erroneous results recently, said, “The probability of a well-designed and manufactured PCR kit is one hundred percent. There is no possibility of missing a positive case in any way. However, it is worth mentioning that each kit is unique. There is a sensitivity limit. If the viral load on the person is below this, the kit may not be able to detect it. Apart from these, some negative effects that may occur during sampling from the person, storage conditions of the kit, and problems encountered during application may cause undesirable results.
Anatolia Geneworks R&D Director and co-founder Molecular Biologist Dr. Elif Akyüz, on the other hand, explained that they developed 12 new coronavirus kits upon requests from various countries and said: